VIA FACSIMILE AND EMAIL March 3, 2010 Adamis Pharmaceutical Corporation 2658 Del Mar Heights Road, #555 Del Mar, California 92014 Attention: President Re: Termination of Merger Agreement

Dear Dennis:

This letter is to confirm our agreement today to terminate the Agreement and Plan of Reorganization among La Jolla Pharmaceutical Company, Jewel Merger Sub, Inc., and Adamis Pharmaceutical Corporation, dated December 4, 2009. We regret that we have been unable to obtain the approvals needed to consummate the merger and appreciate your efforts and investments made in pursuit of this transaction. Upon termination, neither party shall have any obligations, financial or otherwise, to the other party.

We wish you the best in your endeavors.

Sincerely,

/s/ Deirdre Y. Gillespie, M.D.
Deirdre Y. Gillespie, M.D.
Chief Executive Officer

Agreed and Acknowledged as of March 3, 2010

Adamis Pharmaceutical Corporation

By: /s/ Dennis Carlo, Ph.D.
Dennis Carlo, Ph.D.
Chief Executive Officer

cc: Kevin Kelso, Esq.